News

Mirage News1d
Research Reveals Trigger for EGFR Inhibitor Cytokine Storms
In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events (irAEs) that occur when the ...
SciELO4d
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
The probing of the NSCLC kinome has identified numerous nonoverlapping driver genomic events, including epidermal growth factor receptor (EGFR) gene mutations. This review provides a synopsis of ...
AlphaGalileo5d
EGFR inhibitor-linked cytokine storms: study uncovers the trigger
In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events ...
Pharmaceutical Technology6d
ASCO25: AbbVie flexes ADC Phase I data as NSCLC market opportunity beckons
AbbVie’s telisotuzumab adizutecan achieved an ORR of 63% in EGFR-mutant NSCLC patients, with current ADC options in this ...